Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Caredx

Clinical trials sponsored by Caredx, explained in plain language.

CareDx CDNA NASDAQ

Diagnostics company specializing in transplant monitoring tests.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 4

New blood test may predict cancer relapse after transplant

Knowledge-focused Not yet recruiting

This study is testing a new blood test called AlloHeme that looks for tiny traces of a patient's own cells after a stem cell transplant. The goal is to see if the test can predict whether leukemia or MDS will come back before it happens. About 400 adults who have had or will have…

Sponsor: CareDx • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:37 UTC